Anne Sosna RN, BSN

Clinical Nurse Educator, Puma Biotechnology

Appearances

Industry Sponsored Session | Reduce the Risk of Recurrence in HER2+ Breast Cancer: Proactive Treatment Management Strategies (non-CE) Presentation by Puma Biotechnology
Date
November 6, 2020
Please join us for this educational program on Friday, November 6th at 12:15 PM EST to learn more about NERLYNX® (neratinib) for HER2+ Breast Cancer including how to anticipate and mitigate TKI adverse events…
Speaker
Anne Sosna, RN, BSN
Clinical Nurse Educator, Puma Biotechnology